From: Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
Factors | Number of patients | LRPFS | OS | ||
---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | ||
Age (years) | |||||
< 66 | 12 | ||||
≥66 | 15 | 0.23 (0.064–0.86) | 0.029 | 0.86 (0.28–2.67) | 0.79 |
Radiation dose | |||||
< 45 Gy | 9 | ||||
≥45 Gy | 18 | 0.043 (0.0049–0.38) | 4.00E-03 | 0.27 (0.077–0.96) | 0.044 |
Pretreatment CA19–9 (U/ml) | |||||
< 300 | 17 | ||||
≥300 | 10 | 3.39 (0.85–13.54) | 0.084 | 1.87 (0.63–5.55) | 0.26 |
Tumor location | |||||
Body/Tail | 11 | ||||
Head/Neck | 16 | 0.73(0.21–2.58) | 0.62 | 0.61 (0.20–1.9) | 0.39 |